PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022 Sep 13, 2021
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Aug 4, 2021
PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Jul 21, 2021
Delic Holdings Inc. Announces Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers… Jun 25, 2021
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other… Jun 24, 2021
